Brian Madow M.D., Ph.D.

Brian Madow

Brian Madow
M.D., Ph.D.

Clinical Professor of Ophthalmology, Director Retina Service, Department of ophthalmology, Retina specialist, Vitreoretinal surgeon, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

Department of Ophthalmology

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Retina

Contact Information
Ross Eye Institute
1176 Main Street
Buffalo, New York 14209
Phone: 7168817916
brianmad@buffalo.edu


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD


Education and Training:

  • PhD, Automation in Ophthalmology, Technical University- Sofia (2015)
  • Fellowship, Retina, Bascom Palmer Eye Institute (2009)
  • Residency, Ophthalmology, University of Pennsylvania (2008)
  • MS, Automation, Technical university - Sofia (2004)
  • Internship, Cornell University (2003)
  • Fellowship, Vitreoretina, University of Tel-Aviv (1992)
  • Residency, Ophthalmology, Medical Academy Sofia (1990)
  • MD, Medicine, Medical University of Varna (1984)

Employment:

  • Clinical Professor of Ophthalmology, Ophthalmology, University at Buffalo (2021-present)
  • Director of the Retina Service, Ophthalmology, University of Buffalo. Ross Eye Institute (2021-present)
  • Associate Program Director, Ophthalmology, University of Florida Jacksonville (2019–2021)
  • Clinical Associate Professor of Ophthalmology, Ophthalmology, University of Florida, Jacksonville (2018–2021)
  • Clinical Associate Professor of Ophthalmology, Ophthalmology, University of South Florida (2015–2018)
  • Founding director of Uveitis Reading Center, Ophthalmology, University of South Florida (2013–2018)
  • Clinical Assistant Professor, Ophthalmology, University of Florida (2009–2015)
  • Clinical Instructor in Ophthalmology, Ophthalmology, Bascom Palmer Eye Institute, University of Miami (2008–2009)
  • Clinical Instructor of Ophthalmology, Ophthalmology, University of Pennsylvania. Scheie Eye Institute (2005–2008)
  • Medical/technical director Fundus Photograph Reading Center, Ophthalmology, University of Pennsylvania (2003–2005)
  • Senior Clinical Assistant Professor, Ophthalmology, Medical Academy- Sofia, Bulgaria (1993–1995)
  • Clinical Assistant Professor, Ophthalmology, Medical Academy Sofia (1986–1993)
See all (2 more)

Awards and Honors:

  • The Clinical Uveitis Research Award (2011)

Grants and Sponsored Research:

  • September 2018–August 2020
    Randomized Clinical Trial Assessing the Effects of Pneumatic Vitreolysis on Vitreomacular Traction
    Role: Principal Investigator
  • March 2013–March 2018
    First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
    National Eye Institute
    Role: Principal Investigator
    $240,000
  • August 2013–June 2017
    A Randomized, Placebo-controlled, Parallel-Group, Double-Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease
    Role: Principal Investigator
  • August 2012–September 2016
    A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study Assessing the Safety and Efficacy of Intravitreal injection for the Treatment of active, Non-Infectious Uveitis of the Posterior Segment of the eye
    Role: Principal Investigator
  • May 2013–July 2016
    A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the With Amnestic Mild Alzheimer's Disease (Prodromal AD) Cognitive Impairment Due to Efficacy and Safety of MK-8931 (SCH 900931)
    Role: Principal Investigator
  • March 2012–May 2016
    A Randomized Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects with Non-infectious Intermediate, Posterior, or Pan- uveitis currently controlled with systemic treatment
    Role: Principal Investigator
    $9,000
  • January 2011–January 2016
    Multi-center Uveitis Steroid Treatment (MUST) Trial
    John Hopkins University
    Role: Co-Principal Investigator
    $278,419
  • July 2009–October 2013
    Studies of the Ocular Complications of AIDS (SOCA)
    National Eye Institute Grant
    Role: Co-Principal Investigator
    $115,525
  • July 2009–March 2013
    Sub Investigator A Phase III, Double-Masked, Multicenter, Randomized, Active Treatment–Controlled Study of the Efficacy and Safety of 0.5 mg and 2.0 mg Ranibizumab Administered Monthly or on an as Needed Basis (PRN) in Patients with Subfoveal Neovascular Age-Related Macular Degeneration (HARBOR)
    Role: Co-Principal Investigator
    $395,000
  • July 2009–November 2012
    A Phase III, Double-Masked, Multi-Center, Randomized, Sham-Controlled Study of the Efficacy and Safety Of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus (RISE)
    Role: Co-Principal Investigator
    $544,120

Patents:

  • ADVANCED PROTECTIVE CLEAR DOME SHIELD FOR OPTICAL INSTRUMENTS (2021)
  • Quantitative image analysis applied to the grading of vitreous haze (2016)


Professional Memberships:

  • Medical Society of the State of New York (2021–present)
  • Erie County Medical Society (2021–present)
  • Duval County Medical Society (2018–2021)
  • Florida Medical Association (2015–2019)
  • Florida Society of Ophthalmology (2013–2019)
  • American Uveitis Association (2013–present)
  • American Society of Retinal Specialists (2012–present)
  • Tampa Bay Ophthalmological Society (2009–present)
  • American Academy of Ophthalmology (2005–present)
  • Association for Research and Vision in Ophthalmology (1996–present)

Presentations:

  • "Management of Neovascular Glaucoma by retina specialist" Annual Glaucoma Conference - Buffalo (2021)
  • "Automated remote visual field test results visualization" The annual meeting for Research and Vision in Ophthalmology (2019)
  • "Vitreous haze" Investigators meeting for Uveitis Clinical Trial (2014)

Service Activities:

  • Ophthalmology promotion committee; Member (2021–present)
  • University at Buffalo, Ross Eye Institute; Director of retinal service (2021–present)
  • University of Florida, Jacksonville; Compliance officer for the department of ophthalmology (2018–2021)
  • University of Florida Jacksonville; Faculty Council (2018–2021)
  • ; Representative of the Florida Society of Ophthalmology to the Florida Medical Society (2016–2018)
  • NIH, NEI; NIH grant reviewer (2016–present)
  • Florida Society of Ophthalmology; Board of the directors (2015–2018)
  • University of South Florida Physician Group; Board of the directors (2014–2017)
  • University of South Florida; Faculty Council (2010–2014)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Ross Eye Institute
1176 Main Street
Buffalo, New York 14209
Phone: 7168817916
brianmad@buffalo.edu

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD